Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal Cancer

Clinical trial NCT00262990 · COMPLETED

Trial details

NCT number: NCT00262990
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Ovarian Cancer Fallopian Tube Cancer Peritoneal Neoplasms

Start date: 2005-11-01
Primary completion: 2010-02-01
Enrollment: 829

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.